NCT06974331Completed
Effect of Multimedia Protocol About Asthma Control
Effect of Multimedia Protocol About Asthma Control on Asthmatic Children's Adaptation in the Era of Climate Changes
Source: ClinicalTrials.gov · Last updated 8 Oct 2026
Brief summary (registry, in English)
This study aims to evaluate the effect of multimedia protocol about asthma control on asthmatic children's adaptation in the era of climate changes.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 65 (actual)
- First submitted
- 22 Apr 2025
- Start date
- 1 Sept 2024
- Primary completion date
- 30 Jul 2026
- Lead sponsor
- Mansoura University
- Diseases
- Asthma
- NCT number
- NCT06974331
What you commit to
- Study type: Interventional
- Participants enrolled: 65
- From 1 Sept 2024 to the primary completion date, 30 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Any child suffering from other chronic disease or disability, as confirmed by a medical practitioner.
Other
- \- Children with severe or acute asthma attacks as confirmed by a medical practitioner.
Who the study is looking for
- Chronic asthmatic children (aged 7-11 years).
- Both urban and rural asthmatic children.
- Children and their mothers who have not received current or prior guidance about asthma control with the repercussions of climate changes.
- Children whose mothers is educated.
Age in the registry: 7 years to 11 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mansoura University Coordinator of this site? Confirm its status | Al Mansurah | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.